Raveendra Dayam

2.1k total citations
43 papers, 1.8k citations indexed

About

Raveendra Dayam is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Raveendra Dayam has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 23 papers in Molecular Biology and 20 papers in Virology. Recurrent topics in Raveendra Dayam's work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and Biochemical and Molecular Research (13 papers). Raveendra Dayam is often cited by papers focused on HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (20 papers) and Biochemical and Molecular Research (13 papers). Raveendra Dayam collaborates with scholars based in United States, Italy and India. Raveendra Dayam's co-authors include Nouri Neamati, Laith Q. Al‐Mawsawi, Tino W. Sanchez, Jinxia Deng, Nouri Neamati, Rambabu Gundla, Shizuko Sei, Robert H. Shoemaker, J.A.R.P. Sarma and Antonio Garofalo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Raveendra Dayam

43 papers receiving 1.8k citations

Peers

Countries citing papers authored by Raveendra Dayam

Since Specialization

Citations

This map shows the geographic impact of Raveendra Dayam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raveendra Dayam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raveendra Dayam more than expected).

Fields of papers citing papers by Raveendra Dayam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raveendra Dayam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raveendra Dayam. The network helps show where Raveendra Dayam may publish in the future.

Co-authorship network of co-authors of Raveendra Dayam

This figure shows the co-authorship network connecting the top 25 collaborators of Raveendra Dayam. A scholar is included among the top collaborators of Raveendra Dayam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raveendra Dayam. Raveendra Dayam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Review on PARP1 Inhibitors: Pharmacophore Modeling, Virtual and Biological Screening Studies to Identify Novel PARP1 Inhibitors 2014 ·Current Topics in Medicinal Chemistry ·(unknown), J.A.R.P. Sarma, (unknown), Raveendra Dayam, Shili Xu, Nouri Neamati	12
2	Design, Synthesis and Screening Studies of Potent Thiazol-2-Amine Derivatives as Fibroblast Growth Factor Receptor 1 Inhibitors 2014 ·Current Topics in Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Kalle M. Arunasree, Dharmarajan Sriram, (unknown), Nouri Neamati, Raveendra Dayam, J.A.R.P. Sarma	4
3	Development of α-glucosidase inhibitors by room temperature C–C cross couplings of quinazolinones 2013 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), (unknown), (unknown), Rambabu Gundla, T. Chiranjeevi, (unknown), (unknown), Uma Addepally, Raveendra Dayam, C. Venkata Rao, Balaram Patro	22
4	Insilico studies on anthrax lethal factor inhibitors: Pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer 2010 ·Journal of Molecular Graphics and Modelling ·Jyoti Roy, (unknown), (unknown), (unknown), (unknown), Rambabu Gundla, Raveendra Dayam, J.A.R.P. Sarma	6
5	Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors 2009 ·Journal of Molecular Graphics and Modelling ·(unknown), (unknown), Rambabu Gundla, (unknown), (unknown), Raveendra Dayam, (unknown), Sarma A.R.P. Jagarlapudi, Nouri Neamati	6
6	Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors 2008 ·Bioorganic & Medicinal Chemistry ·Mario Sechi, G. Rizzi, Alessia Bacchi, Mauro Carcelli, Dominga Rogolino, Nicolino Pala, Tino W. Sanchez, (unknown), Raveendra Dayam, Nouri Neamati	52
7	Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach 2008 ·Journal of Medicinal Chemistry ·Rambabu Gundla, (unknown), (unknown), (unknown), J.A.R.P. Sarma, Raveendra Dayam, Nouri Neamati	121
8	Four-tiered π interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity 2008 ·Virology ·Laith Q. Al‐Mawsawi, Anneleen Hombrouck, Raveendra Dayam, Zeger Debyser, Nouri Neamati	20
9	Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: Effects of the phenyl substituent and the linker orientation 2008 ·Bioorganic & Medicinal Chemistry ·Li‐Fan Zeng, (unknown), Tino W. Sanchez, (unknown), Raveendra Dayam, Nouri Neamati, Ya-Qiu Long	20
10	Inhibitory profile of a LEDGF/p75 peptide against HIV‐1 integrase: Insight into integrase–DNA complex formation and catalysis 2008 ·FEBS Letters ·Laith Q. Al‐Mawsawi, Frauke Christ, Raveendra Dayam, Zeger Debyser, Nouri Neamati	46
11	Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore 2007 ·Bioorganic & Medicinal Chemistry ·Jinxia Deng, Tino W. Sanchez, Laith Q. Al‐Mawsawi, Raveendra Dayam, Rosendo Augusto Yunes, Antonio Garofalo, Michael B. Bolger, Nouri Neamati	118
12	HIV-1 Integrase Inhibitors 2007 ·Drugs in R&D ·Raveendra Dayam, Laith Q. Al‐Mawsawi, Nouri Neamati	71
13	Patented small molecule inhibitors of p53–MDM2 interaction 2006 ·Expert Opinion on Therapeutic Patents ·Jinxia Deng, Raveendra Dayam, Nouri Neamati	18
14	Design of Second Generation HIV-1 Integrase Inhibitors 2006 ·Current Pharmaceutical Design ·Jinxia Deng, Raveendra Dayam, Laith Q. Al‐Mawsawi, Nouri Neamati	20
15	Mining the NCI antiviral compounds for HIV-1 integrase inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·Jinxia Deng, James A. Kelley, Joseph J. Barchi, Tino W. Sanchez, Raveendra Dayam, Yves Pommier, Nouri Neamati	21
16	Discovery and Structure–Activity Relationship Studies of a Unique Class of HIV‐1 Integrase Inhibitors 2005 ·ChemMedChem ·Raveendra Dayam, Tino W. Sanchez, Nouri Neamati	10
17	Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors 2004 ·Bioorganic & Medicinal Chemistry ·Francesca Aiello, Antonella Brizzi, Antonio Garofalo, Fedora Grande, Gaetano Ragno, Raveendra Dayam, Nouri Neamati	26
18	Small-Molecule HIV-1 Integrase Inhibitors: the 2001-2002 Update 2003 ·Current Pharmaceutical Design ·Raveendra Dayam, Nouri Neamati	65
19	Analogue based design of MMP-13 (Collagenase-3) inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·J.A.R.P. Sarma, G. Rambabu, (unknown), Raveendra Dayam, M. Vithal	2
20	3-D QSAR studies on new dibenzyltin(IV) anticancer agents by comparative molecular field analysis (CoMFA) 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Dick de Vos, Raveendra Dayam, J.A.R.P. Sarma, Sujit Roy	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact